News
| 8 min read
Scientists continue to ring alarm bells about the risks associated with the continued misuse of antimicrobials and advocate for innovative treatments, improved surveillance, and greater public health education.
| 10+ min read
Scientists leverage the gut microbiome-brain connection to develop new treatments for autism spectrum disorders.
| 6 min read
Researchers use fruit flies to figure out how genetic mutations disrupt biology and how drugs might reverse these effects.
| 6 min read
CRISPR gene editing directly and indirectly drives advances in cardiovascular disease therapeutic development.
| 10+ min read
Researchers are tapping into the regenerative power of stem cells to treat central nervous system disorders.
| 4 min read
A GLP-grade non-replicative Leishmania major parasite protects hamsters from lethal leishmaniasis infection, setting the stage for human clinical trials and the first potential vaccine for leishmaniasis.
| 5 min read
Researchers employ CRISPR technology in a variety of creative ways to control the spread of vector-borne illnesses.
| 3 min read
Transplanted astrocyte precursor cells promote healing in mouse brains after strokes.
| 3 min read
A biopharmaceutical company established a new method for isolating and editing hematopoietic stem cells from patients to provide stem cell therapies for diseases such as sickle cell disease.
| 5 min read
Christine Brown develops CAR T cell therapies that may one day provide a long-sought-after cure for malignant brain cancers.
| 3 min read
Experiments in ferrets show that a prophylactic spray cuts SARS-CoV-2 replication by more than 90 percent by priming the innate immune system.
| 2 min read
Unlike other cells in the body that mount a strong immune response against microbial invaders, skin cells use an epigenetic mechanism to ignore most of the microbes they see. These findings reveal a potential new drug target for inflammatory skin diseases.
